2025
Donor, Recipient, and Parent Characteristics Associated with Poor Pediatric Sibling Hematopoietic Stem Cell Donor Pre-Donation Health-Related Quality-of-Life; Early Results of the Donorkids QL Study
Switzer G, Bruce J, Shaw B, Kuniyil V, Varni J, Butler B, Erickson C, Mussetter A, Aguayo-Hiraldo P, Anderson E, Aquino V, Boone K, Chewning J, Dahlberg A, Dvorak C, Haight A, Hoag J, Hudspeth M, Jacobsohn D, Kasow K, Kitko C, Miller H, Olson T, Pawlowska A, Prasad V, Quigg T, Scaradavou A, Shah N, Shenoy S, Silva J, Terwilliger N, Wiener L, Yanik G, Yu L, Pulsipher M. Donor, Recipient, and Parent Characteristics Associated with Poor Pediatric Sibling Hematopoietic Stem Cell Donor Pre-Donation Health-Related Quality-of-Life; Early Results of the Donorkids QL Study. Transplantation And Cellular Therapy 2025, 31: s95-s96. DOI: 10.1016/j.jtct.2025.01.151.Peer-Reviewed Original ResearchHealth-related quality-of-lifeQuality-of-lifePoorer health-related quality-of-lifeFamily unitFamily cohesionPredictors of HRQoL.Aged 5Low parental education levelSelf-reported depressionParental demographic characteristicsParental education levelDonation processParental HRQoLPsychosocial scoresPartnership statusLow family cohesionQL studiesFamily characteristicsPsychosocial effectsHRQoLEmployment statusEducation levelHRQoL.Pre-donationInterview data
2024
Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people?
Alpert A, Obedin-Maliver J, Gjelsvik A, Amanullah S, Shireman T, Blosnich J. Does cancer clinical trial enrollment for sexual and gender minority people differ from heterosexual, cisgender people? Contemporary Clinical Trials 2024, 146: 107695. PMID: 39303766, DOI: 10.1016/j.cct.2024.107695.Peer-Reviewed Original ResearchBehavioral Risk Factor Surveillance SurveyCancer clinical trial enrollmentClinical trial enrollmentTrial enrollmentRisk Factor Surveillance SurveySGM peopleNon-SGM individualsClinical trial participationCancer disparitiesSurveillance SurveyReport participationGender minority peopleTrial participantsSGM statusSGM individualsPartnership statusLogistic regressionCisgender peopleData collection methodsEnrollmentOncological treatmentOddsMinority peopleParticipantsSGM
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply